Martin Bornhäuser

1999–2025 年に発表

257
論文数
29,063
被引用数
96
h 指数
245
i10 指数

被引用数

Martin Bornhäuser の年別被引用数1989 年: 被引用 1 件1990 年: 被引用 1 件2000 年: 被引用 5 件2001 年: 被引用 14 件2002 年: 被引用 17 件2003 年: 被引用 50 件2004 年: 被引用 60 件2005 年: 被引用 91 件2006 年: 被引用 70 件2007 年: 被引用 110 件2008 年: 被引用 112 件2009 年: 被引用 139 件2010 年: 被引用 162 件2011 年: 被引用 135 件2012 年: 被引用 178 件2013 年: 被引用 179 件2014 年: 被引用 205 件2015 年: 被引用 200 件2016 年: 被引用 230 件2017 年: 被引用 210 件2018 年: 被引用 211 件2019 年: 被引用 940 件2020 年: 被引用 1,014 件2021 年: 被引用 1,064 件2022 年: 被引用 941 件2023 年: 被引用 808 件2024 年: 被引用 1,303 件2025 年: 被引用 531 件2026 年: 被引用 20 件1991〜1999 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,832 件、この内訳の 22%ドイツ: 引用元論文 1,408 件、この内訳の 10.9%中国: 引用元論文 1,102 件、この内訳の 8.5%イタリア: 引用元論文 764 件、この内訳の 5.9%イギリス: 引用元論文 743 件、この内訳の 5.8%フランス: 引用元論文 678 件、この内訳の 5.3%オランダ: 引用元論文 458 件、この内訳の 3.6%スペイン: 引用元論文 443 件、この内訳の 3.4%カナダ: 引用元論文 376 件、この内訳の 2.9%スイス: 引用元論文 300 件、この内訳の 2.3%日本: 引用元論文 291 件、この内訳の 2.3%オーストラリア: 引用元論文 267 件、この内訳の 2.1%
0%22%その他 25%

分野

  • Medicine73.3%
  • Biochemistry, Genetics and Molecular Biology13.1%
  • Immunology and Microbiology6.9%
  • Engineering2.2%
  • Computer Science1.5%
  • Materials Science1%
  • その他2%

トピック

  • Acute Myeloid Leukemia Research11.1%
  • Hematopoietic Stem Cell Transplantation7.8%
  • Mesenchymal stem cell research5%
  • Acute Lymphoblastic Leukemia research3.4%
  • Immune Cell Function and Interaction3.3%
  • CAR-T cell therapy research3.2%
  • その他66.2%

共著者

全論文

検索で開く
  1. Sorafenib Maintenance After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia With FLT3–Internal Tandem Duplication Mutation (SORMAIN)

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Christian Brandts, Susanne Harnisch, Michael Wittenberg, Heinz‐Gert Hoeffkes, Susanne Rospleszcz, Alexander Burchardt, Andreas Neubauer, Markus Brugger, Konstantin Strauch, Carmen Schade‐Brittinger, Stephan Metzelder - Journal of Clinical Oncology 2020 被引用: 551

  2. Apoptosis in mesenchymal stromal cells induces in vivo recipient-mediated immunomodulation

    著者: , , , , , , , , , , , , , , , , , , , , - Science Translational Medicine 2017 被引用: 654

  3. Proof of concept for a rapidly switchable universal CAR-T platform with UniCAR-T-CD123 in relapsed/refractory AML

    著者: , , , , , , , , , , , , , - Blood 2021 被引用: 164

  4. Immune landscapes predict chemotherapy resistance and immunotherapy response in acute myeloid leukemia

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Science Translational Medicine 2020 被引用: 209

  5. Immunomodulatory Properties of Mesenchymal Stromal Cells: An Update

    著者: , , , , , , , , - Frontiers in Cell and Developmental Biology 2021 被引用: 205

  6. The proteogenomic subtypes of acute myeloid leukemia

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Daniel Hübschmann, Lars Kaderali, Jürgen Cox, Bernhard Brüne, Christoph Röllig, Christian Thiede, Björn Steffen, Martin Bornhäuser, Andreas Trumpp, Henning Urlaub, Kimberly Stegmaier, Hubert Serve, Matthias Mann, Thomas Oellerich - Cancer Cell 2022 被引用: 147

  7. Tumor-infiltrating plasmacytoid dendritic cells are associated with survival in human colon cancer

    著者: , , , , , , , , , , , , , , , , , , - Journal for ImmunoTherapy of Cancer 2021 被引用: 121

  8. Reinforcement Learning for Precision Oncology

    著者: , , , - Cancers 2021 被引用: 90

  9. Distribution and levels of cell surface expression of CD33 and CD123 in acute myeloid leukemia

    著者: , , , , , , , , , , , - Blood Cancer Journal 2014 被引用: 352

  10. Mesenchymal stromal cell-associated migrasomes: a new source of chemoattractant for cells of hematopoietic origin

    著者: , , , , , , - Cell Communication and Signaling 2023 被引用: 89

  11. Measurable residual disease-guided treatment with azacitidine to prevent haematological relapse in patients with myelodysplastic syndrome and acute myeloid leukaemia (RELAZA2): an open-label, multicentre, phase 2 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Christian Thiede - The Lancet Oncology 2018 被引用: 354

  12. TP53 abnormalities correlate with immune infiltration and associate with response to flotetuzumab immunotherapy in AML

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Blood Advances 2020 被引用: 153

  13. Deep learning detects acute myeloid leukemia and predicts NPM1 mutation status from bone marrow smears

    著者: , , , , , , , , , , , , , - Leukemia 2021 被引用: 119

  14. Immune dysfunction signatures predict outcomes and define checkpoint blockade–unresponsive microenvironments in acute myeloid leukemia

    著者: , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Investigation 2022 被引用: 92

  15. Increasing Incidence of Chronic Graft-versus-Host Disease in Allogeneic Transplantation: A Report from the Center for International Blood and Marrow Transplant Research

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Robert Peter Gale, John Koreth, Nelson J. Chao, Mahmoud Aljurf, Brenda Cooper, Mary J. Laughlin, Jack W. Hsu, Peiman Hematti, Leo F. Verdonck, Melhelm M. Solh, Maxim Norkin, Vijay Reddy, Rodrigo Martino, Shahinaz M. Gadalla, Jenna D. Goldberg, Philip L. McCarthy, Josè Antonio Pérez-Simón, Nandita Khera, Ian D. Lewis, Yoshiko Atsuta, Richard F. Olsson, Wael Saber, Edmund K. Waller, Didier Blaise, Joseph A. Pidala, Paul J. Martin, Prakash Satwani, Martin Bornhäuser, Yoshihiro Inamoto, Daniel J. Weisdorf, Mary M. Horowitz, Steven Z. Pavletic - Biology of Blood and Marrow Transplantation 2014 被引用: 435

  16. Bone marrow central memory and memory stem T-cell exhaustion in AML patients relapsing after HSCT

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Communications 2019 被引用: 186

  17. CEBPA mutations in 4708 patients with acute myeloid leukemia: differential impact of bZIP and TAD mutations on outcome

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Katja Sockel, Malte von Bonin, Carsten Müller‐Tidow, Uwe Platzbecker, Wolfgang E. Berdel, Hubert Serve, Gerhard Ehninger, Martin Bornhäuser, Johannes Schetelig, Christian Thiede, for the Study Alliance Leukemia (SAL) - Blood 2021 被引用: 164

  18. Convergent synthesis of diversified reversible network leads to liquid metal-containing conductive hydrogel adhesives

    著者: , , , , , , , , , , - Nature Communications 2021 被引用: 163

  19. Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2009 被引用: 719

  20. Deep learning identifies Acute Promyelocytic Leukemia in bone marrow smears

    著者: , , , , , , , , , , , , , , , , - BMC Cancer 2022 被引用: 76

  21. Venetoclax synergizes with gilteritinib in FLT3 wild-type high-risk acute myeloid leukemia by suppressing MCL-1

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Binje Vick, Irmela Jeremias, Andreas Trumpp, Jeroen Krijgsveld, Carsten Müller‐Tidow, Sascha Dietrich - Blood 2022 被引用: 102

  22. A Dynamic rRNA Ribomethylome Drives Stemness in Acute Myeloid Leukemia

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Discovery 2022 被引用: 70

  23. Role of Donor Clonal Hematopoiesis in Allogeneic Hematopoietic Stem-Cell Transplantation

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Guido Kobbe, Markus Wiesneth, Michael Koldehoff, Gèrard Socié, Nicolaus Kröger, Lars Bullinger, Christian Thiede, Frédérik Damm - Journal of Clinical Oncology 2018 被引用: 220

  24. Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis

    著者: , , , , , , , , , , , - Blood 2002 被引用: 1,729